Entrepreneurs in Residence

Michael Beaubaire received his undergraduate degree from the University of Pennsylvania's Wharton School of Business and his Medical Doctorate degree from Northwestern University. After a number of years in clinical and hospital practice at McGaw Northwestern Medical Center and Advocate Healthcare, Dr. Beaubaire shifted gears into the financial sector and worked at Salomon Bros, Lincoln Park Capital and HCA Capital Partners. He is currently a board member and advisor to a number of biotech companies. Michael currently helps Helix 51 companies with partnering and fundraising activities from investors and bioscience companies.

Tom Cox, JD brings a unique perspective to his practice, which focuses on serving the needs of privately held businesses, their executives, and their investors. In particular, he works closely with emerging and growth-oriented businesses in initial organizational, structural, and shareholder activities and board matters, equity incentive plan development and implementation, general corporate, commercial, and real estate activities, supplier relationships, and general regulatory compliance matters, particularly in the healthcare industry. He regularly supports the legal and business needs of both early stage and middle market firms in connection with equity and debt financings, joint ventures, mergers, acquisitions, and divestitures. Representative clients range from start-ups licensing novel technologies from universities to multi-national, private equity-backed businesses.

Edwin Moore, PhD brings 40 years of biopharmaceutical, pharmaceutical, and clinical diagnostic industry experience from global companies, Baxter Healthcare Corp, and Abbott Laboratories, in R&D product development. During his career, he has held various roles in CMC pre-clinical product development for recombinant therapeutic proteins and for IV parenteral small molecule products in Analytical Method Development, Stability Testing, Formulation, as well as leading overall pre-clinical product development for a recombinant therapeutic protein product. He has held positions from bench scientist, R&D Product Development, to Sr. Director, Global Analytical Method Development and Validation.

J. Peter Paredes, JD has over 16 years of experience in all aspects of patent prosecution, litigation, licensing, and counseling. Peter developed patent portfolios for clients resulting in five acquisitions or licensing arrangements for over $150 million. Peter works with startups, universities, and investment firms to provide strategic intellectual property acquisition, licensing, and enforcement.

Kathleen Wisemandle is a researcher and executive coach specializing in the intersection of neurodiversity and leadership. With over 30 years in the biotechnology and pharmaceutical industry including Abbvie, Takeda, Baxter, and Astellas, she has built and led global teams, guiding clinical operations from IND through NDA across multiple therapeutic areas and is an expert in clinical development.  She is also the founder of Aspire to Grow, a consulting and coaching firm dedicated to helping professionals navigate complex career landscapes with clarity and confidence. She holds a BS in Biochemistry from Michigan State University and an MS in Organizational Change and Learning from Northwestern University, where she also earned certifications in Designing for Organizational Efficiency and Executive Coaching.